Recombinant Anti-CA72-4 x Anti-CD3 Bispecific Antibody (Triple Body) is designed to be expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-CA72-4 antibody are both extended with the scFv fragment from an anti-CD3 antibody. This BsAb can retarget T cells to tumor cells. It is designed for the research of Gastrointestinal cancer; Ovarian cancer; Colon cancer; Gastric cancer; Breast cancer; Adenocarcinomas therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY